# TRANK1

## Overview
TRANK1, or tetratricopeptide repeat and ankyrin repeat containing 1, is a gene that encodes a protein involved in critical cellular processes through its role in protein-protein interactions. The protein, characterized by its tetratricopeptide and ankyrin repeats, functions primarily in transcriptional regulation and is active in both the nucleus and cytoplasm. This dual localization allows it to influence gene expression and cytoplasmic signaling pathways, which are essential for cellular homeostasis. TRANK1 is particularly significant in neurodevelopment and immune response, suggesting its involvement in brain function and behavior. The protein's interactions within synaptic networks and its association with psychiatric disorders such as bipolar disorder and schizophrenia highlight its potential impact on cognitive functions and behavioral responses (Li2020Independent; Alfieri2017Synaptic).

## Function
TRANK1 (tetratricopeptide repeat and ankyrin repeat containing 1) encodes a protein that plays a significant role in various cellular processes through its involvement in protein-protein interactions. The protein contains tetratricopeptide and ankyrin repeats, which are structural motifs that facilitate these interactions, crucial for its function in transcriptional regulation. TRANK1 is active in both the nucleus and cytoplasm, where it influences cellular signaling pathways. This dual localization allows TRANK1 to participate in the regulation of gene expression and other nuclear processes, as well as cytoplasmic signaling events that are essential for maintaining cellular homeostasis.

In terms of organismal outcomes, TRANK1 is implicated in neurodevelopment and immune response, suggesting its involvement in brain function and behavior. The protein's role in these processes indicates that it may contribute to the development and maintenance of neural circuits and the modulation of immune system activity. By affecting these critical biological pathways, TRANK1 potentially influences cognitive functions and behavioral responses, highlighting its importance in maintaining normal physiological functions in humans.

## Clinical Significance
The TRANK1 gene has been identified as a susceptibility gene for bipolar disorder (BD), with its expression levels significantly higher in the postmortem brain tissue of BD patients compared to healthy controls (Lai2021Impaired). Genetic studies have highlighted the association of specific single nucleotide polymorphisms (SNPs) near TRANK1, such as rs9834970 and rs4789, with an increased risk of BD in both East Asian and European populations (Li2020Independent). These SNPs are linked to alterations in TRANK1 mRNA expression, suggesting that changes in gene expression contribute to the genetic risk of developing BD (Li2020Independent).

TRANK1 is also implicated in schizophrenia, with studies showing that genes correlated with TRANK1 are enriched in pathways related to synapses and circadian entrainment, which are often altered in BD subjects (Li2020Independent). The gene's expression is influenced by the interferon signaling pathway, and its upregulation has been linked to increased blood-brain barrier permeability and central immune activation, contributing to neuroinflammation, a key factor in BD development (Lai2021Impaired). The potential role of TRANK1 in these psychiatric disorders underscores the need for further research to elucidate its pathophysiological mechanisms.

## Interactions
TRANK1 is involved in various protein-protein interactions, particularly within synaptic networks. It is part of the synaptic interactome associated with the p140Cap adaptor molecule, which plays a crucial role in synaptic functions such as dendritic spine initiation and maturation. This interaction network is linked to several psychiatric and neurological disorders, including schizophrenia and bipolar disorder (Alfieri2017Synaptic). 

TRANK1's expression is highly correlated with CACNA1C, a gene significant in bipolar disorder and schizophrenia, suggesting a potential interaction or co-regulation in pathways related to these psychiatric conditions (Li2020Independent). The gene is also part of dense protein-protein interaction networks enriched in pathways related to synapses, circadian entrainment, and calcium signaling, which are relevant to psychiatric disorders (Li2020Independent).

While specific physical interactions of TRANK1 with other proteins or nucleic acids are not detailed, its involvement in these networks indicates its potential role in modulating synaptic functions and contributing to the pathogenesis of psychiatric disorders. Further research is needed to elucidate the precise molecular interactions and mechanisms involving TRANK1.


## References


[1. (Li2020Independent) Wenqiang Li, Xin Cai, Hui-Juan Li, Meng Song, Chu-Yi Zhang, Yongfeng Yang, Luwen Zhang, Lijuan Zhao, Weipeng Liu, Lu Wang, Minglong Shao, Yan Zhang, Chen Zhang, Jun Cai, Dong-Sheng Zhou, Xingxing Li, Li Hui, Qiu-Fang Jia, Na Qu, Bao-Liang Zhong, Shu-Fang Zhang, Jing Chen, Bin Xia, Yi Li, Xueqin Song, Weixing Fan, Wei Tang, Wenxin Tang, Jinsong Tang, Xiaogang Chen, Weihua Yue, Dai Zhang, Yiru Fang, Xiao Xiao, Ming Li, Luxian Lv, and Hong Chang. Independent replications and integrative analyses confirm trank1 as a susceptibility gene for bipolar disorder. Neuropsychopharmacology, 46(6):1103–1112, August 2020. URL: http://dx.doi.org/10.1038/s41386-020-00788-4, doi:10.1038/s41386-020-00788-4. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41386-020-00788-4)

[2. (Alfieri2017Synaptic) Annalisa Alfieri, Oksana Sorokina, Annie Adrait, Costanza Angelini, Isabella Russo, Alessandro Morellato, Michela Matteoli, Elisabetta Menna, Elisabetta Boeri Erba, Colin McLean, J. Douglas Armstrong, Ugo Ala, Joseph D. Buxbaum, Alfredo Brusco, Yohann Couté, Silvia De Rubeis, Emilia Turco, and Paola Defilippi. Synaptic interactome mining reveals p140cap as a new hub for psd proteins involved in psychiatric and neurological disorders. Frontiers in Molecular Neuroscience, June 2017. URL: http://dx.doi.org/10.3389/fnmol.2017.00212, doi:10.3389/fnmol.2017.00212. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnmol.2017.00212)

[3. (Lai2021Impaired) Jianbo Lai, Jiajun Jiang, Peifen Zhang, Caixi Xi, Lingling Wu, Xingle Gao, Yaoyang Fu, Danhua Zhang, Yiqing Chen, Huimin Huang, Yiyi Zhu, and Shaohua Hu. Impaired blood‐brain barrier in the microbiota‐gut‐brain axis: potential role of bipolar susceptibility gene trank1. Journal of Cellular and Molecular Medicine, 25(14):6463–6469, May 2021. URL: http://dx.doi.org/10.1111/jcmm.16611, doi:10.1111/jcmm.16611. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.16611)